2015 | | ALDH1 is a prognostic factor for patients treated with neoadjuvant chemoradiotherapy and radical resection for stage III rectal cancer. | 김영배, 서광욱, 오승엽, 이다근, 임현이 |
2019 | | Change in microcalcifications on mammography after neoadjuvant chemotherapy in breast cancer patients: correlation with tumor response grade and comparison with lesion extent | 강두경, 김태희, 임현이, 정용식 |
2016 | | Clinical Significance of the Endoscopic Finding in Predicting Complete Tumor Response to Preoperative Chemoradiation Therapy in Rectal Cancer | 김영배, 오승엽, 임선교 |
2013 | | Comparison of oncological outcomes between neoadjuvant and adjuvant chemotherapy combined with surgery for resectable synchronous colorectal liver metastases. | 김도윤, 김영배, 서광욱, 오승엽 |
2013 | | Magnetic resonance imaging enhancement features before and after neoadjuvant chemotherapy in patients with breast cancer: a predictive value for responders. | 강두경, 김구상, 김태희, 임현이 |
2012 | | Magnetic resonance imaging patterns of tumor regression after neoadjuvant chemotherapy in breast cancer patients: correlation with pathological response grading system based on tumor cellularity | 강두경, 강석윤, 김구상, 김태희, 임현이, 정용식 |
2014 | | MET expression is associated with disease-specific survival in breast cancer patients in the neoadjuvant setting. | 고영화 |
2017 | | Oncologic Outcome of ypT1-2N0 Rectal Cancer After Neoadjuvant Chemoradiotherapy Compared With pT1-2N0 Rectal Cancer | 김영배, 서광욱, 오승엽 |
2014 | | Prognostic significance of the ratio of absolute neutrophil to lymphocyte counts for breast cancer patients with ER/PR-positivity and HER2-negativity in neoadjuvant setting. | 고영화 |
2014 | | Utility of MRI and PET/CT after neoadjuvant chemotherapy in breast cancer patients: correlation with pathological response grading system based on tumor cellularity. | 강두경, 강석윤, 김구상, 김태희, 안영실, 임현이, 정용식 |
2016 | | Value of volume-based metabolic parameters for predicting survival in breast cancer patients treated with neoadjuvant chemotherapy | 강두경, 강석윤, 김지영, 김태희, 안영실, 윤준기, 임현이, 정용식, 한세환 |